Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Covid-19: Hamdard Labs to begin clinical trials of immunity-boosting drugs Infuza, Kulzam

Ruchika Sharma8 Sept 2020 12:19 PM IST

New Delhi: Health and wellness firm Hamdard Laboratories on Monday said it is going to start a clinical trial of its two immunity boosting medicines...

Dr Reddys unveils generic Fulvestrant injection for breast cancer in US

Ruchika Sharma8 Sept 2020 11:40 AM IST

Faslodex is a prescription medicine used to treat advanced breast cancer or breast cancer that has spread to other parts of the body.

Alembic Pharma secures USFDA nod for Treprostinil Injection to treat pulmonary arterial hypertension

Ruchika Sharma7 Sept 2020 2:08 PM IST

Treprostinil Injection is indicated for the treatment of pulmonary arterial hypertension(PAH; WHO group 1) to dimnish symptoms associated with...

PIL against 10 top pharma Cos in SC alleging sale of Remdesivir and Favipiravir without valid license

Ruchika Sharma7 Sept 2020 1:26 PM IST

It has also made 10 pharmaceutical companies, including Cipla Ltd, Dr Reddy's Laboratories Ltd, Hetero Labs Ltd and Zydus Cadila Healthcare Ltd,...

Healthcare focused SaaS startup Zealthix raises USD 1.1 million in seed round

Omron Healthcare India aims at Rs 150 cr revenue in FY21

Ruchika Sharma7 Sept 2020 12:16 PM IST

One of the key drivers for the growth is the rising awareness about the importance of home monitoring and management of blood pressure and respiratory...

PBT Raises Rs 18 Crore on Social Stock Exchange for Free Healthcare Initiative

BPPI sales turnover up 94 percent to Rs 146.59 crore in Q1

Ruchika Sharma7 Sept 2020 9:30 AM IST

New Delhi: The Bureau Of Pharma PSUs Of India (BPPI) reported a 94.21 percent increase in its sales turnover at Rs 146.59 crore for the quarter...

Sanofi Plans Ingredients Unit IPO Within Months: Report

Ruchika Sharma7 Sept 2020 9:00 AM IST

Paris: Sanofi, the French pharmaceutical giant, plans to sell shares in its drug-ingredients division in the next few months, a senior executive...

JnJ vaccine raises neutralizing antibodies, prevents severe COVID-19 in hamsters

Ruchika Sharma6 Sept 2020 10:45 AM IST

The vaccine, co-developed by the Beth Israel Deaconess Medical Center and Johnson & Johnson (JnJ), uses a common cold virus, called adenovirus...

Eli Lilly diabetes drug Trulicity gets USFDA nod

Ruchika Sharma6 Sept 2020 10:15 AM IST

The additional doses of Trulicity will be available in US pharmacies in late September.

CureVac anticipates to produce COVID-19 vaccine at scale by 2020 end

Ruchika Sharma6 Sept 2020 10:00 AM IST

Germany: German biotech company Curevac expects to be able to produce the COVID-19 vaccine it is developing at scale by the end of the year,...

Roche Itovebi recommended by CHMP for EU approval for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancer

Roche gets Emergency Use Authorization from USFDA for SARS-CoV-2, Influenza A/B Test

Ruchika Sharma6 Sept 2020 9:45 AM IST

Basel: Roche has recently announced that the cobas® SARS-CoV-2 & Influenza A/B Test for use on the cobas® 6800/8800...

COVID-19 Vaccine: AstraZeneca AZD1222 phase 1/2 trials to begin in Japan

Ruchika Sharma6 Sept 2020 9:15 AM IST

Tokyo: Astrazeneca said on Friday it is beginning Phase 1/2 clinical trials in Japan of its coronavirus vaccine candidate.Trials of the vaccine, known...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok